IL-6 drives T cell proliferation by Van Epps, Heather L.
IN THIS ISSUE | The Journal of Experimental Medicine  1387
Text by Heather L. Van Epps
hvanepps@rockefeller.edu
Neutrophils take the easy way out
To migrate out of blood vessels into inflamed 
tissues, blood cells must cross both the vessel 
endothelium and basement membrane (BM). 
According to Wang and colleagues (page 1519), 
protein-sparse exit sites in the BM pave the 
way for this cellular escape.
The signals required for blood cells to 
adhere to sites of vessel inflammation and 
to squeeze through endothelial cell (EC) 
junctions are well defined. But it is un-
clear how the cells then traverse the 
tough, underlying network of BM proteins. 
Migrating cells, such as neutrophils, produce proteases that can cleave 
BM proteins, which may help the cells drill through the BM.
But Wang and colleagues favor a less destructive model, as drilling 
holes in the BM could inflict irreversible vessel damage. They now show 
that steady-state expression of certain (but not all) BM proteins—including 
laminin 10 and collagen IV—is patchy in small veins, creating discrete areas 
of low protein expression. Most of these low expression regions were 
aligned with both EC junctions and gaps between pericytes—structural 
cells that help synthesize BM proteins. These protein-sparse regions ap-
peared to be the preferred sites for inflammation-induced neutrophil exit.
These data suggest that exiting neutrophils take the path of least resistance, 
a finding that makes perfect sense to senior author Sussan Nourshargh. “If you 
have a door, you use it,” says Nourshargh. “You don’t blast through the wall.”
How neutrophils find these sites, and whether other cell types use the 
same exits, is now under investigation. 
IL-6 drives T cell proliferation
Hyperresponsiveness to the IL-6 family of cytokines triggers a spontaneous 
rheumatoid arthritis (RA)-like disease in mice. On page 1459, Sawa and 
colleagues show that excessive IL-6 signaling drives hyperproliferation of 
CD4+ T cells, which then attack the joints.
IL-6 has been implicated in RA and other T cell–driven autoimmune 
diseases. Indeed, a previous study by this group showed that an activating 
mutation in the gp130 subunit of the IL-6 receptor caused a lymphocyte-
driven arthritis in mice. But the mechanism was unclear. The authors now 
show that disease development in these mice depends on CD4+ T cells, but 
not on cytolytic CD8+ T cells or antibody-producing B cells.
The CD4+ cells did not appear to cause disease because of an affinity for 
joint-specific antigens. Rather, the cells simply proliferated excessively in the 
mutant mice. This hyperproliferation was not the fault of the T cell, as wild-
type CD4+ T cells also multiplied excessively and caused disease when 
transferred into irradiated mutant mice.
Rather, the gp130 mutation caused nonhematopoietic cells to produce 
excess IL-7—a growth factor that triggers T cell proliferation. This is the first 
evidence that IL-6 family cytokines can trigger IL-7 production.
These data suggest that IL-6, which is elevated in the serum and joints 
of patients with RA, might exacerbate disease by inducing IL-7 and thus 
driving T cell activation. What causes the overstimulated T cells to attack the 
joints in the first place remains a mystery. 
Gut bacteria side-step 
lymph nodes
Invasive bacteria can take more than one route 
from the gut to distant organs, say Barnes and 
colleagues on page 1591.
According to conventional wisdom, pathogenic 
gut bacteria spread to distant tissues via an 
orderly march from gut to local lymph nodes (LNs) 
and then on to distant organs. But some mutant 
bugs that cannot invade the lymphoid tissues of 
the gut can still spread, hinting at the existence of 
an alternative route.
Barnes and colleagues infected mice orally 
with Yersinia pseudotuberculosis. They noted two 
waves of bacteria that spread to both the spleen 
and liver in the infected mice. The first wave 
occurred within 30 minutes of infection and was 
rapidly cleared from these distant organs. The 
second began later and stuck around.
Only the second wave of bacteria side-stepped 
the LNs, as mice lacking Peyer’s patches—the gut 
lymphoid tissue that bacteria traverse to reach the 
LNs—developed only late-stage infections in the 
liver and spleen.
Marking individual bacteria with unique 
oligonucleotide tags revealed that the bugs 
entrenched in distant organs were descendants 
only of those that migrated later, after first 
replicating in the gut—possibly because replication 
triggers the expression of virulence factors that 
protect the bug against the host immune response.
How the disseminating bugs bypass the LNs 
remains to be determined. Perhaps they piggy-
back on dendritic cells, which can reach directly 
across the gut epithelium to grab antigens and 
then head straight for the circulation. 
Neutrophils exit veins through 
protein-sparse regions in the 
basement membrane (circled).
Dissemination of gut bacteria to the liver and 
spleen of mice is comparable in the presence 
(closed triangles) and absence (open triangles) 
of Peyer’s patches.